Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structural features enable selective binding and improved metabolic stability in drug candidates. Commonly employed in the preparation of active pharmaceutical ingredients requiring high enantiomeric purity. Also utilized in research settings for the construction of nitrogen-containing heterocyclic compounds with potential biological activity.